Valeant, Actavis, Mylan Said Interested in Buying Pfizer's Generics Unit -- Reuters
14 January 2014 - 10:11PM
Dow Jones News
Drug makers Valeant Pharmaceuticals International Inc., Actavis
PLC and Mylan Inc. have all expressed interest in buying Pfizer
Inc.'s branded generics business, but no active discussions are
going on at this time, Reuters reported, citing three people close
to the matter.
Pfizer is aware of each of the companies' interest but isn't yet
ready to entertain a deal as it prepares the groundwork for a
potential separation of the generics business, Reuters
reported.
Full story at
http://www.reuters.com/article/2014/01/14/us-pfizer-valeant-idUSBREA0D0CZ20140114
Write to copydesk@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Valeant Pharma (NYSE:VRX)
Historical Stock Chart
From Apr 2024 to May 2024
Valeant Pharma (NYSE:VRX)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Bausch Health Cos (New York Stock Exchange): 0 recent articles
More Valeant Pharmaceuticals International Inc. News Articles